BioNeutral Group, Inc. (BONU) SEC Filings
http://bioneutral.com/Home/Page/products-ogiene http://spectrasan.com/rokdownloads/sales_materials/ogiene-sell-sheet.pdf The Importance about Spectrasan: Ygiene and Ogiene from BONU is listed as the top products on the Spectrasan website: Ygiene and Ogiene from BONU is listed as the top products on the Spectrasan website:
Read below from some older news to possibly link an affiliation:
BioTech Medical, LLC, a privately held company announced Monday that it is prepared with its new product SpectraSan 24, a new advanced surface disinfectant to immediately respond to the current Influenza A (H1N1) epidemic. BioTech Medical, LLC is a distributor for PURE Bioscience (Nasdaq: PURE), creators of the patented silver dihydrogen citrate (SDC) antimicrobial. …
PURE trades on the NASDAQ at $1.10+ per share:
These relationships are definitely something that we should keep our eye on for sure. http://bioneutral.com/Home/Page/bioneutral-group
Dr. Andy Kielbania, was with was Rohm and Haas which was a very huge multi-billion dollar company. In my opinion, him being here with BONU is a huge hint that he is not here because of something that could be considered small change. See below:
Quote: Dow Chemical
Rohm and Haas | Company Information from ICIS In April 2009, Dow Chemical completed its $78/share takeover of Rohm and Haas. Dow Chemical will integrate its acquired Rohm and Haas business into the newly formed ‘Advanced Materials Division’ and will be headed by Pierre Brondeau.
bought out Rohm and Haas
for $78.00 per share.
When you click on the old Rohm and Haas
website, it takes you to Dow Chemicals
website: http://www.rohmhaas.com For inquiring minds, Dow Chemicals trade on the NYSE at $40.00+ per shareunder the ticker pf DOW: http://www.dow.com/ More proof that Dr. Andy Kielbania, PhD, CEO, Chief Scientific Officer and Director for BONU was an instrumental part of Rohm and Haas which was bought out by Dow Chemical:
At Rohm and Haas we thank Dr. Edward Firouztale, Dr. Peter Cartier, and Dr. Andy Kielbania for scholarly discussions and assistance with the research.
Dr. Andy Kielbania, PhD
The Chief Scientist with over 35 years experience in the specialty chemical field, including coatings, adhesives, personal care, biotechnology and pharmaceuticals. He has previously held positions at Rohm and Haas (do people realize how big these Companies are?) where he assumed senior level positions in research and development. In 1993, Dr. Kielbania joined National Starch and Chemical Company (part of ICI) as research and development Director. Dr. Kielbania is the inventor on 21 patents and has published many technical articles. He is the winner of awards in new technology development to improve new business opportunities and also research and development improvements. He received his PhD in organic chemistry from the University of California at Berkeley (good grief it does not get any better than that other than Harvard and MIT!) and has post doctoral experience at Stanford University.
Disinfectant that quickly wipes out swine flu, anthrax spores, is being tested at NJIT
Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature. Hospital induced Staph Infection & H1N1 Flu Virus
The required EPA testing procedures occurred at ATS Labs.
BioNeutral’s Ygiene™ Kills Dangerous MRSA in Seconds. Hospital Acquired Infections (HAI’s), The big one ( staph Infection)
BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based life science company, reports that its Ygiene™ Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature. The required EPA testing procedures occurred at ATS Labs.
MRSA, or Methicillin-resistant Staphylococcus aureus, is a very serious health threatening microorganisms present in many health care facilities and community environments. MRSA is one of the more serious antibiotic resistant heath threatening microorganisms that contributes to Hospital Acquired Infections (HAI’s). In the U.S. alone, over two million people annually are afflicted with Hospital Acquired Infections with approximately one hundred thousand people dying. Worldwide Hospital Acquired Infections are on the rise and will lead to hundreds of thousands needless deaths annually. MRSA is also becoming a serious issue associated with Community Acquired Infections such as school and campus settings. With its power to rapidly and totally eliminate MRSA in less than one minute, BioNeutral’s Ygiene™ Hospital Grade Antimicrobial will be a significant part of the future solution for controlling Hospital Acquired Infections and Community Acquired Infections.
BioNeutral’s Consumer Grade Ygiene™ Delivers a 100% Total Kill on Contact of Swine Flu (H1N1) Virus – For the Home
BioNeutral Announces 100% Total Kill of Swine Flu (H1N1) on Virtual Contact of This Pandemic Causing Virus in an Independent ...
Swine Flu Campaign Waits on Vaccine
Only Third of Supply Is Expected for First Round of Vast Effort
By Rob Stein
Washington Post Staff Writer
Sunday, August 23, 2009
New York Times
Monday, August 24, 2009
BioNeutral Group Hosts Discussions with Four of the World’s Largest Health Care Companies
All Interested in Ygiene™ Sporicidal Antimicrobial Performance on Skin and Surfaces
Monday, August 24, 2009
211 Warren Street
Newark, NJ 07103
3 Month Daily View